Cardiovascular Systems Inc. announced that the first patients in the United States were treated using the OrbusNeich Teleport Microcatheter (Teleport), which recently received U.S. Food and Drug Administration (FDA) 510(k) clearance.
Researchers have mapped the active-state structure of the angiotensin II type 1 receptor, the target of widely prescribed drugs to regulate blood pressure and kidney function. The study, published online Jan. 10 in Cell, was conducted by researchers in the Blavatnik Institute at Harvard Medical School and colleagues at Duke University Medical Center.
The higher expense and lower frame rates of 3-D cardiac ultrasound systems have limited their adoption over the past ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
January 31, 2019 — Nearly half (48 percent, 121.5 million in 2016) of all adults in the United States have some type of ...
Northwestern Medicine scientists have discovered a novel signaling pathway that promotes healing after a heart attack. The study, published in Cell Metabolism, demonstrates for the first time that the metabolism of dead heart cells by macrophages reprograms the immune cells to launch an anti-inflammatory response and stimulate tissue repair.
Rising temperatures stemming from global climate change may increase the number of infants born with congenital heart defects (CHD) in the U.S. over the next two decades, according to new research in the Journal of the American Heart Association.1 This may also result in as many as 7,000 additional cases over an 11 year-period in eight representative states — Arkansas, Texas, California, Iowa, North Carolina, Georgia, New York and Utah.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
January 30, 2019 — Updated atrial fibrillation (AFib) treatment guidelines released this week now recommend new oral ...
In recent years, there has been a lot of focus by vendors on developing better stenting technologies to treat peripheral ...
The U.S. Food and Drug Administration (FDA) has cleared the Magnetom Lumina 3 Tesla (3T) magnetic resonance imaging (MRI) scanner from Siemens Healthineers.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
XableCath Inc., announced that its XableCath blunt and abrasion tip catheters were cleared by the U.S. Food and Drug Administration (FDA) as peripheral crossing catheters. The catheters have been safely and successfully used to cross challenging lesions in both arterial chronic total occlusions (CTOs) and chronic obstructive venous lesions. The recent crossing FDA clearance adds to the previous clearances for endovascular support.
Thubrikar Aortic Valve Inc. announced the first human implant of the Optimum TAV using their transcatheter aortic valve implantation (TAVI) system.
LivaNova PLC announced the publication of three separate studies highlighting the performance of its sutureless aortic valve, Perceval.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
There was a lot of hype and high hopes pinned on bioresorbable stent technologies as the way of the future two years ago ...
DAIC Editor Dave Fornell takes a tour of some of the most interesting new artificial intelligence (AI) imaging ...
The American College of Cardiology host the third Advancing the Cardiovascular Care of the Oncology Patient course in Washington on Jan. 25-27, 2019. The event brought together top experts in both cardiology and oncology to review new and relevant science in this rapidly evolving field.